LON:C4XDC4X Discovery Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding C4X Discovery Holdings PLC Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 15.60 +0.10 (+0.65 %) (As of 06/5/2020 04:00 PM ET) Add Compare Share Today's Range 15.20Now: GBX 15.60▼ 1650-Day Range 14MA: GBX 15.37▼ 20.6052-Week Range 7Now: GBX 15.60▼ 55.19Volume348,603 shsAverage Volume2,983 shsMarket Capitalization£18.60 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsEarningsInsider TradesHeadlines C4X Discovery Holdings plc operates as a drug discovery and development company in the United Kingdom. The company has a suite of proprietary technologies across the drug discovery process, including Taxonomy 3, a novel in silico platform technology that utilises proprietary ground-breaking mathematical algorithms to perform complex multivariate analysis of genetic data; Conformetrix, a technology platform which allows 3D-shapes of free drug molecules to be measured from experimental data, giving medicinal chemists new and unprecedented insights into the behaviour and physical properties of drug molecules; and MolPlex. Its product pipeline comprises Oral Orexin-1, an antagonist for the treatment of addiction; Oral GPR142 and GLP-1, an agonist for the treatment of type 2 diabetes; Oral Nrf-2 activators and IL-17 inhibitors for the treatment of inflammatory disorders; and various products for the treatment of oncology. The company has collaboration agreement with the University of Bristol, the University of Reading, the University of Oxford, and the University of Manchester; and a discovery partnership with Horizon Discovery Group plc to develop synthetic lethality targets in oncology. The company was formerly known as Schosween 24 plc and changed its name to C4X Discovery Holdings plc October 2014. C4X Discovery Holdings plc was founded in 2007 and is based in Manchester, the United Kingdom.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for C4X Discovery. Previous Next 3.1 Community Rank Outperform VotesC4X Discovery has received 86 “outperform” votes. (Add your “outperform” vote.)Underperform VotesC4X Discovery has received 51 “underperform” votes. (Add your “underperform” vote.)Community SentimentC4X Discovery has received 62.77% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about C4X Discovery and other stocks. Vote “Outperform” if you believe C4XD will outperform the S&P 500 over the long term. Vote “Underperform” if you believe C4XD will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldC4X Discovery does not currently pay a dividend.Dividend GrowthC4X Discovery does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, C4X Discovery insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of C4X Discovery is -1.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of C4X Discovery is -1.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioC4X Discovery has a P/B Ratio of 1.64. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 3.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.62 out of 5 stars Industry, Sector and Symbol Stock Exchange LON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:C4XD Previous Symbol CUSIPN/A CIKN/A Webwww.c4xdiscovery.com Phone+44-161-2355085Debt Debt-to-Equity Ratio5.47 Current Ratio7.99 Quick Ratio7.99Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales£7.06 million Price / Sales2.63 Cash FlowGBX 5.34 per share Price / Cash Flow2.92 Book ValueGBX 9.50 per share Price / Book1.64Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees47 Outstanding Shares119,203,000Market Cap£18.60 million Next Earnings DateN/A OptionableNot Optionable LSE:C4XD Rates by TradingView Receive C4XD News and Ratings via Email Sign-up to receive the latest news and ratings for C4XD and its competitors with MarketBeat's FREE daily newsletter. C4X Discovery (LON:C4XD) Frequently Asked Questions How has C4X Discovery's stock been impacted by COVID-19 (Coronavirus)? C4X Discovery's stock was trading at GBX 9.75 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, C4XD stock has increased by 60.0% and is now trading at GBX 15.60. View which stocks have been most impacted by Coronavirus. How were C4X Discovery's earnings last quarter? C4X Discovery Holdings PLC (LON:C4XD) issued its earnings results on Wednesday, April, 29th. The company reported ($5.02) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($5.50) by $0.48. View C4X Discovery's earnings history. Has C4X Discovery been receiving favorable news coverage? News coverage about C4XD stock has been trending positive this week, InfoTrie Sentiment reports. The research group identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. C4X Discovery earned a news sentiment score of 3.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the near term. View the latest news aboutC4X Discovery. Who are some of C4X Discovery's key competitors? Some companies that are related to C4X Discovery include Orthocell (OCC), Cynata Therapeutics (CYP), Oxford Biodynamics (OBD), Pediapharm (PDP), Biotron (BIT), Synairgen (SNG), 4d Pharma (DDDD), Navidea Biopharmaceuticals (NAVB), Equillium (EQ), Sirona Biochem (SBM), Immutep (IMM), e-Therapeutics (ETX), Emerald Health Therapeutics (EMH), Promis Neurosciences (PMN) and Navidea Biopharmaceuticals (NAVB). View all competitors. What other stocks do shareholders of C4X Discovery own? Based on aggregate information from My MarketBeat watchlists, some companies that other C4X Discovery investors own include Rio Tinto (RIO), Ryder System (R), Pearson (PSON), Moss Bros Group (MOSB), Inditex (ITX), Inland Homes (INL), Fundsmith Emerging Equities Trust (FEET), easyJet (EZJ), Card Factory (CARD) and Berkeley Group (BKG). Who are C4X Discovery's key executives? C4X Discovery's management team includes the following people: Dr. Clive James Dix, CEO & Director (Age 64)Mr. Bradley Richard Hoy, CFO & Director (Age 56)Dr. Justian Craig Fox, Chief Scientific Officer & Director (Age 44)Ms. Bhavna Hunjan, Head of Corp. Strategy & Devel.Mr. Mark James Sullivan, Company Sec. What is C4X Discovery's stock symbol? C4X Discovery trades on the London Stock Exchange (LON) under the ticker symbol "C4XD." How do I buy shares of C4X Discovery? Shares of C4XD and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is C4X Discovery's stock price today? One share of C4XD stock can currently be purchased for approximately GBX 15.60. How big of a company is C4X Discovery? C4X Discovery has a market capitalization of £18.60 million and generates £7.06 million in revenue each year. C4X Discovery employs 47 workers across the globe. What is C4X Discovery's official website? The official website for C4X Discovery is www.c4xdiscovery.com. How can I contact C4X Discovery? C4X Discovery's mailing address is 53 Portland Street, MANCHESTER, M1 3LD, United Kingdom. The company can be reached via phone at +44-161-2355085. This page was last updated on 6/6/2020 by MarketBeat.com Staff
